-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WKmWpreYkv/yuHsl71WXFvwniuHT8RNf5XDsH1PxTM9r2qU1g+k7spqbxQHmpENC vG5rvm+nDpo8MqGwNGNt6w== 0001391636-09-000005.txt : 20091221 0001391636-09-000005.hdr.sgml : 20091221 20091218181852 ACCESSION NUMBER: 0001391636-09-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20091221 DATE AS OF CHANGE: 20091218 EFFECTIVENESS DATE: 20091221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CELL BIOSCIENCES INC CENTRAL INDEX KEY: 0001381825 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-96789 FILM NUMBER: 091251118 BUSINESS ADDRESS: STREET 1: 3040 OAKMEAD VILLAGE DRIVE CITY: CUPERTINO STATE: CA ZIP: 94304 BUSINESS PHONE: 408 510-5500 MAIL ADDRESS: STREET 1: 3040 OAKMEAD VILLAGE DRIVE CITY: CUPERTINO STATE: CA ZIP: 94304 D 1 primary_doc.xml X0603 D LIVE 0001381825 CELL BIOSCIENCES INC 3040 OAKMEAD VILLAGE DRIVE CUPERTINO CA 94304 408 510-5500 DELAWARE Signal Analytics, Inc. None Corporation true Timothy Harkness c/o Cell Biosciences, Inc. 3040 Oakmead Village Drive Santa Clara CA 95051 Executive Officer Director David Barker c/o Cell Biosciences, Inc. 3040 Oakmead Village Drive Santa Clara CA 95051 Director James Blair c/o Domain Associates One Palmer Square, Suite 515 Princeton NJ 08542 Director A. Blaine Bowman c/o Cell Biosciences, Inc. 3040 Oakmead Village Drive Santa Clara CA 95051 Director Julie Eskay-Eagle c/o The Wellcome Trust Gildos Building, 215 Euston Road London X0 NW1 2BE Director Jack Nielson c/o Novo A/S Krogshoejvej 41 Bagsvaerd G7 DK 2880 Director James Woody c/o Latterell Venture Partners 1 Embarcadero Center, Suite 4050 San Francisco CA 94111 Director Jason Novi c/o Cell Biosciences, Inc. 3040 Oakmead Village Drive Santa Clara CA 95051 Executive Officer Biotechnology Decline to Disclose 06 false 2009-12-04 false true true Offering of Series E Preferred Stock ("Series E"), and the underlying shares of Common Stock isuable upon conversion of the Series E. true $5,250,000 of the Issuer's Series E was issued in exchange for outstanding senior notes of target company and $3,999,999 of the Issuer's Series E was issued in connection with a venture capital financing. 0 9750000 9249999 500001 false 3 0 0 0 false CELL BIOSCIENCES INC /s/ Timothy Harkness Timothy Harkness President and CEO 2009-12-17 -----END PRIVACY-ENHANCED MESSAGE-----